JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, C. E.
Right arrow Articles by Scriabine, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, C. E.
Right arrow Articles by Scriabine, A.

Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery

CE Johnson, OS Steinsland and A Scriabine

Rabbit ear arteries were isolated and perfused with Krebs-bicarbonate solution. Brief periods of supramaximal nerve stimulation caused reproducible constriction of the arteries, which was inhibited by dopamine at concentrations ranging from 3.3 X 10(-9) to 3.3 X 10(-7) M. The inhibitory effect of dopamine was antagonized by sulpiride and by verapamil. The dose-response curve to dopamine was shifted to the right by both sulpiride and verapamil, indicative of competitive inhibition. The dopamine antagonist activity of verapamil does not appear to be a consequence of its Ca++ channel inhibitory activity because other calcium antagonists (e.g., nitrendipine and diltiazem) had no similar action.

Volume 226, Issue 3, pp. 802-805, 09/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.